| 标题 |
EGFR S442 ectodomain mutation confers cetuximab resistance that can be overcome by ERBB2 blockade with trastuzumab-deruxtecan |
| 网址 | |
| DOI | |
| 其它 |
期刊:Cancer letters 作者:Harmych SJ; Joshi N; Tanaka H; Bogatcheva G; Ramirez MA; et al 出版日期:2026/08/28 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)